{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:16:52Z","timestamp":1785521812901,"version":"3.56.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2001,3,1]],"date-time":"2001-03-01T00:00:00Z","timestamp":983404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Rheumatology"],"published-print":{"date-parts":[[2001,3]]},"DOI":"10.1053\/berh.2000.0130","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T13:54:50Z","timestamp":1032443690000},"page":"125-137","source":"Crossref","is-referenced-by-count":10,"title":["How is it best to treat early rheumatoid arthritis patients?"],"prefix":"10.1053","volume":"15","author":[{"given":"James R.","family":"O'Dell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/berh.2000.0130_RF1","first-page":"1436","article-title":"The Dunlop\u2013Dottridge Lecture: prognosis in inflammatory arthritis: the value of HLA genotyping and the oncological analogy","volume":"24","author":"Emery","year":"1997","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/berh.2000.0130_RF2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2165\/00115677-199701030-00004","article-title":"Rheumatoid arthritis. Emerging evidence for the benefits of early and aggressive therapy","volume":"3","author":"Tugwell","year":"1997","journal-title":"Disease Management and Health Outcomes"},{"key":"10.1053\/berh.2000.0130_RF3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/rheumatology\/XXXIV.suppl_4.87","article-title":"Therapeutic approaches for early rheumatoid arthritis. How early? How aggressive?","volume":"34","author":"Emery","year":"1995","journal-title":"British Journal of Rheumatology"},{"key":"10.1053\/berh.2000.0130_RF4","first-page":"2208","article-title":"Patients with rheumatoid arthritis benefit from early second-line therapy: 5-year follow-up of a prospective double-blind placebo-controlled study","volume":"22","author":"Egsmose","year":"1995","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/berh.2000.0130_RF5","first-page":"623","article-title":"Consequences of delayed therapy with second-line agents in rheumatoid arthritis: a 3 year followup on the hydroxychloroquine in early rheumatoid arthritis (HERA) study","volume":"27","author":"Tsakonas","year":"2000","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/berh.2000.0130_RF6","doi-asserted-by":"crossref","first-page":"699","DOI":"10.7326\/0003-4819-124-8-199604150-00001","article-title":"The effectiveness of early treatment with \u2018second-line\u2019 antirheumatic drugs. A randomized, controlled trial","volume":"124","author":"van der Heide","year":"1996","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/berh.2000.0130_RF7","first-page":"1072","article-title":"Longterm mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well","volume":"25","author":"Symmons","year":"1998","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/berh.2000.0130_RF8","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(97)01300-7","article-title":"Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis","volume":"350","author":"Boers","year":"1997","journal-title":"Lancet"},{"key":"10.1053\/berh.2000.0130_RF9","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJM199507203330302","article-title":"The effect of glucocorticoids on joint destruction in rheumatoid arthritis","volume":"333","author":"Kirwan","year":"1995","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/berh.2000.0130_RF10","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/S0140-6736(98)08513-4","article-title":"Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomized trial","volume":"353","author":"M\u00f6tt\u00f6non","year":"1999","journal-title":"Lancet"},{"key":"10.1053\/berh.2000.0130_RF11","first-page":"425","article-title":"Interrelationship of outcome measures and process variables in early rheumatoid arthritis. A comparison of radiologic damage, physical disability, joint counts and acute phase reactants","volume":"21","author":"Van Leeuwen","year":"1994","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/berh.2000.0130_RF12","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/rheumatology\/XXXIV.suppl_4.74","article-title":"Joint erosions and patients with early rheumatoid arthritis","volume":"34","author":"van der Heijde","year":"1995","journal-title":"British Journal of Rheumatology"},{"key":"10.1053\/berh.2000.0130_RF13","first-page":"230","article-title":"the majority of patients with rheumatoid arthritis have erosive disease at presentation when magnetic resonance imaging of the dominant hand is employed","volume":"36","author":"McGonagle","year":"1997","journal-title":"British Journal of Rheumatology"},{"key":"10.1053\/berh.2000.0130_RF14","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0889-857X(21)00471-3","article-title":"The changing face of therapy for rheumatoid arthritis","volume":"21","author":"Kremer","year":"1995","journal-title":"Rheumatic Disease Clinics of North America"},{"key":"10.1053\/berh.2000.0130_RF15","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0889-857X(05)70360-4","article-title":"Methotrexate use in rheumatoid arthritis","volume":"23","author":"O'Dell","year":"1997","journal-title":"Rheumatic Disease Clinics"},{"key":"10.1053\/berh.2000.0130_RF16","doi-asserted-by":"crossref","first-page":"833","DOI":"10.7326\/0003-4819-121-11-199412010-00002","article-title":"Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind, placebo-controlled trial","volume":"121","author":"Morgan","year":"1994","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/berh.2000.0130_RF17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1056\/NEJM199507203330301","article-title":"Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis","volume":"333","author":"Tugwell","year":"1995","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/berh.2000.0130_RF18","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJM199605163342002","article-title":"Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications","volume":"334","author":"O'Dell","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/berh.2000.0130_RF19","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/art.1780370505","article-title":"Minocycline in active rheumatoid arthritis. A double-blind, placebo-controlled trial","volume":"37","author":"Kloppenburg","year":"1994","journal-title":"Arthritis and Rheumatism"},{"key":"10.1053\/berh.2000.0130_RF20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/0003-4819-122-2-199501150-00001","article-title":"Minocycline in rheumatoid arthritis: a 48 week, double-blind, placebo-controlled trial","volume":"122","author":"Tilley","year":"1995","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/berh.2000.0130_RF21","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/art.1780400510","article-title":"Treatment of early rheumatoid arthritis with minocycline or placebo","volume":"40","author":"O'Dell","year":"1997","journal-title":"Arthritis and Rheumatism"},{"key":"10.1053\/berh.2000.0130_RF22","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0140-6736(98)09403-3","article-title":"Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomized, multicentre trial","volume":"353","author":"Smolen","year":"1999","journal-title":"Lancet"},{"key":"10.1053\/berh.2000.0130_RF23","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/1529-0131(200003)43:3<506::AID-ANR5>3.0.CO;2-U","volume":"43","author":"Tugwell","year":"2000","journal-title":"Arthritis and Rheumatism"},{"key":"10.1053\/berh.2000.0130_RF24","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/1529-0131(200003)43:3<495::AID-ANR4>3.0.CO;2-U","article-title":"Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group","volume":"43","author":"Sharp","year":"2000","journal-title":"Arthritis and Rheumatism"},{"key":"10.1053\/berh.2000.0130_RF25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/030097499750042263","article-title":"Leflunomide versus methotrexate: a comparison of the European and American Experience","volume":"112","author":"Schiff","year":"1999","journal-title":"Scandinavian Journal of Rheumatology"},{"key":"10.1053\/berh.2000.0130_RF26","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0140-6736(94)90628-9","article-title":"Randomized double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor \u03b1 (cA2) versus placebo in rheumatoid arthritis","volume":"344","author":"Elliott","year":"1994","journal-title":"Lancet"},{"key":"10.1053\/berh.2000.0130_RF27","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1056\/NEJM199707173370301","article-title":"Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein","volume":"337","author":"Moreland","year":"1997","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/berh.2000.0130_RF28","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1002\/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W","article-title":"Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor \u03b1 monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis","volume":"41","author":"Maini","year":"1998","journal-title":"Arthritis and Rheumatism"},{"key":"10.1053\/berh.2000.0130_RF29","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1056\/NEJM199901283400401","article-title":"A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate","volume":"340","author":"Weinblatt","year":"1999","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/berh.2000.0130_RF30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/ard.48.1.7","article-title":"Factors predicting a poor life prognosis in rheumatoid arthritis: an eight year prospective study","volume":"48","author":"Erhardt","year":"1989","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1053\/berh.2000.0130_RF31","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/rheumatology\/32.8.717","article-title":"Factors predicting death, survival and functional outcome in a prospective study of early rheumatoid disease over fifteen years","volume":"32","author":"Corbett","year":"1993","journal-title":"British Journal of Rheumatology"},{"key":"10.1053\/berh.2000.0130_RF32","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/rheumatology\/36.3.345","article-title":"Comparison of intramuscular methotrexate and gold sodium thiomalate in the treatment of early erosive rheumatoid arthritis: 12 month data of a double-blind parallel study of 174 patients","volume":"36","author":"Rau","year":"1997","journal-title":"British Journal of Rheumatology"},{"key":"10.1053\/berh.2000.0130_RF33","first-page":"S366","article-title":"The treatment of rheumatoid arthritis in 1995: results of a survey","volume":"38","author":"O'Dell","year":"1995","journal-title":"Arthritis and Rheumatism"},{"key":"10.1053\/berh.2000.0130_RF34","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/rheumatology\/34.12.1146","article-title":"Prognostic value of quantitative measurement of rheumatoid factor in early rheumatoid arthritis","volume":"34","author":"Paimela","year":"1995","journal-title":"British Journal of Rheumatology"},{"key":"10.1053\/berh.2000.0130_RF35","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/1529-0131(199809)41:9<1571::AID-ART7>3.0.CO;2-R","article-title":"Radiographic outcome of recent-onset rheumatoid arthritis: a 19-year study of radiographic progression","volume":"41","author":"Wolfe","year":"1998","journal-title":"Arthritis and Rheumatism"},{"key":"10.1053\/berh.2000.0130_RF36","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/rheumatology\/32.suppl_3.9","article-title":"The acute-phase response in relation to radiographic progression in early rheumatoid arthritis: a prospective study during the first three years of the disease","volume":"32","author":"van Leeuwen","year":"1993","journal-title":"British Journal of Rheumatology"},{"key":"10.1053\/berh.2000.0130_RF37","first-page":"9","article-title":"The acute phase and function in early rheumatoid arthritis. C-reactive protein levels correlate with functional outcome","volume":"24","author":"Devlin","year":"1997","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/berh.2000.0130_RF38","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/ard.48.1.7","article-title":"Factors predicting a poor life prognosis in rheumatoid arthritis: an eight year prospective study","volume":"48","author":"Erhardt","year":"1989","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1053\/berh.2000.0130_RF39","doi-asserted-by":"crossref","first-page":"801","DOI":"10.7326\/0003-4819-117-10-801","article-title":"The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis","volume":"117","author":"Weyand","year":"1992","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/berh.2000.0130_RF40","doi-asserted-by":"crossref","first-page":"26","DOI":"10.7326\/0003-4819-120-1-199401010-00005","article-title":"Prediction of long-term mortality in patients with rheumatoid arthritis according to simple questionnaire and joint count measures","volume":"120","author":"Pincus","year":"1994","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/berh.2000.0130_RF41","first-page":"417","article-title":"Patterns of radiological progression in early rheumatoid arthritis: results of an 8-year prospective study","volume":"25","author":"Plant","year":"1998","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/berh.2000.0130_RF42","first-page":"1","article-title":"Early mortality in RA predicted by poor clinical status","volume":"41","author":"Pincus","year":"1992","journal-title":"Bulletin of the Rheumatic Diseases"},{"key":"10.1053\/berh.2000.0130_RF43","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/ard.57.4.209","article-title":"HLA-DRB1 typing in rheumatoid arthritis: predicting response to specific treatments","volume":"57","author":"O'Dell","year":"1998","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1053\/berh.2000.0130_RF44","first-page":"530","article-title":"Radiographic assessment of disease progression in rheumatoid arthritis patients treated with methotrexate or minocycline","volume":"27","author":"Alarcon","year":"2000","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/berh.2000.0130_RF45","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1002\/art.1780391105","article-title":"HLA-DRB1 genes and disease severity in rheumatoid arthritis","volume":"39","author":"Reville","year":"1996","journal-title":"Arthritis and Rheumatism"},{"key":"10.1053\/berh.2000.0130_RF46","first-page":"565","article-title":"Remodeling the pyramid\u2014a concept whose time has come","volume":"16","author":"Wilske","year":"1989","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/berh.2000.0130_RF47","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0140-6736(97)22031-3","article-title":"Rheumatoid arthritis: not yet curable with early intensive therapy","volume":"350","author":"Emery","year":"1997","journal-title":"Lancet"},{"key":"10.1053\/berh.2000.0130_RF48","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0025-6196(24)00526-3","article-title":"The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone:compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis","volume":"24","author":"Hench","year":"1949","journal-title":"Proceedings of the Staff Meetings of the Mayo Clinic"},{"key":"10.1053\/berh.2000.0130_RF49","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0002-9343(94)90131-7","article-title":"Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events","volume":"96","author":"Saag","year":"1994","journal-title":"American Journal of Medicine"},{"key":"10.1053\/berh.2000.0130_RF50","first-page":"667","article-title":"Steroids in rheumatoid arthritis: the honeymoon revisited","volume":"19","author":"Ramos-Remus","year":"1992","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/berh.2000.0130_RF51","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1136\/ard.18.3.173","volume":"18","year":"1959","journal-title":"Annals of Rheumatic Diseases"},{"key":"10.1053\/berh.2000.0130_RF52","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1136\/ard.19.4.331","volume":"19","year":"1960","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1053\/berh.2000.0130_RF53","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/rheumatology\/37.9.930","article-title":"Joint destruction after glucocorticoids are withdrawn in early rheumatoid arthritis","volume":"37","author":"Hickling","year":"1998","journal-title":"British Journal of Rheumatology"},{"key":"10.1053\/berh.2000.0130_RF54","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/rheumatology\/34.4.347","article-title":"Oral steroids as bridge therapy in RA patients starting with parental gold. A randomized double-blind placebo-controlled trial","volume":"34","author":"van Gestel","year":"1995","journal-title":"British Journal of Rheumatology"},{"key":"10.1053\/berh.2000.0130_RF55","first-page":"22","article-title":"As tetraciclinas no tratamento da artrite reumatoid e doencas reumaticas inflamatorias","volume":"82","author":"Sanchez","year":"1968","journal-title":"Brasil Med"},{"key":"10.1053\/berh.2000.0130_RF56","series-title":"Inflammatory Disease and Copper","first-page":"391","article-title":"Antimycoplasma approach to the mechanism and control of rheumatoid disease","author":"Brown","year":"1982"},{"key":"10.1053\/berh.2000.0130_RF57","first-page":"5","article-title":"Antibiotic therapy of rheumatoid arthritis: a retrospective cohort study of 98 patients with 451 patient-years of follow-up","volume":"S8","author":"Brown","year":"1985","journal-title":"International Congress in Rheumatology"},{"key":"10.1053\/berh.2000.0130_RF58","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/art.1780130207","article-title":"The early history of anti-rheumatic drugs","volume":"13","author":"Rodnan","year":"1970","journal-title":"Arthritis and Rheumatism"},{"key":"10.1053\/berh.2000.0130_RF59","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.0954-6820.1942.tb06841.x","article-title":"Salazopyrin, a new sulfanilamide preparation","volume":"110","author":"Svartz","year":"1942","journal-title":"Acta Medica Scandinavica"},{"key":"10.1053\/berh.2000.0130_RF60","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1749-6632.1994.tb24728.x","article-title":"A non-antimicrobial tetracycline inhibits gingival matrix metalloproteinases and bone loss in Porphyromonas gingivalis induced periodontitis in rats","volume":"732","author":"Golub","year":"1994","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1053\/berh.2000.0130_RF61","first-page":"927","article-title":"Tetracyclines suppress matrix metalloproteinase activity in adjuvant arthritis and in combination with flurbiprofen ameliorate bone damage","volume":"19","author":"Greenwald","year":"1992","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/berh.2000.0130_RF62","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1749-6632.1994.tb24771.x","article-title":"Elevation of urinary pyridinoline in adjuvant arthritic rats and its inhibition by doxycycline","volume":"732","author":"Ganu","year":"1994","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1053\/berh.2000.0130_RF63","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/art.1780351007","article-title":"Reduction of the severity of canine osteoarthritis by prophylactic treatment with oral doxycycline","volume":"35","author":"Yu","year":"1993","journal-title":"Arthritis and Rheumatism"},{"key":"10.1053\/berh.2000.0130_RF64","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/00124743-199506000-00012","article-title":"Tetracyclines in the treatment of rheumatoid arthritis: they work, but we do not know the reason(s)","volume":"1","author":"Alarcon","year":"1995","journal-title":"Journal of Clinical Rheumatology"},{"key":"10.1053\/berh.2000.0130_RF65","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00124743-199506000-00011","article-title":"Tetracyclines may be therapeutically beneficial in rheumatoid arthritis, but not for the reasons that you might think","volume":"1","author":"Greenwald","year":"1995","journal-title":"Journal of Clinical Rheumatology"},{"key":"10.1053\/berh.2000.0130_RF66","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0049-0172(99)80004-3","article-title":"Minocycline-induced autoimmune syndromes: an overview","volume":"28","author":"Elkayam","year":"1999","journal-title":"Seminars in Arthritis and Rheumatism"},{"key":"10.1053\/berh.2000.0130_RF67","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1001\/archinte.159.5.493","article-title":"Minocycline and lupuslike syndrome in acne patients","volume":"159","author":"Sturkenboom","year":"1999","journal-title":"Archives of Internal Medicine"},{"key":"10.1053\/berh.2000.0130_RF68","first-page":"289","article-title":"Evolving therapies for peptic ulcer disease: Helicobacter pylori treatment","volume":"3","author":"Cohen","year":"1995","journal-title":"Gastroenterologist"},{"key":"10.1053\/berh.2000.0130_RF69","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1002\/1529-0131(199908)42:8<1691::AID-ANR18>3.0.CO;2-S","article-title":"Treatment of early seropositive rheumatoid arthritis with minocycline: four-year followup of a double-blind, placebo-controlled trial","volume":"42","author":"O'Dell","year":"1999","journal-title":"Arthritis and Rheumatism"},{"key":"10.1053\/berh.2000.0130_RF70","first-page":"S117","article-title":"A phase III trial of etanercept vs methotrexate (MTX) in early rheumatoid arthritis (Enbrel ERA Trial)","volume":"42","author":"Finck","year":"1999","journal-title":"Arthritis and Rheumatism"},{"key":"10.1053\/berh.2000.0130_RF71","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/1529-0131(200003)43:3<522::AID-ANR7>3.0.CO;2-Y","article-title":"Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis","volume":"43","author":"Haugeberg","year":"2000","journal-title":"Arthritis and Rheumatism"},{"key":"10.1053\/berh.2000.0130_RF72","doi-asserted-by":"crossref","first-page":"963","DOI":"10.7326\/0003-4819-119-10-199311150-00001","article-title":"Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis","volume":"119","author":"Laan","year":"1993","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/berh.2000.0130_RF73","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199807303390502","article-title":"Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group","volume":"339","author":"Saag","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/berh.2000.0130_RF74","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1136\/ard.57.12.724","article-title":"Cyclical etidronate increases bone density in the spine and hip of postmenopausal women receiving long term corticosteroid treatment. A double blind, randomised placebo controlled study","volume":"57","author":"Geusens","year":"1998","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1053\/berh.2000.0130_RF75","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1136\/ard.45.11.963","article-title":"Coronary arteritis complicating rheumatoid arthritis","volume":"45","author":"Van Albada-Kiupers","year":"1986","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1053\/berh.2000.0130_RF76","first-page":"2562","article-title":"Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset","volume":"26","author":"Wallberg-Jonsson","year":"1999","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/berh.2000.0130_RF77","first-page":"630","article-title":"The effect of smoking on clinical, laboratory and radiographic status in rheumatoid arthritis","volume":"27","author":"Wolfe","year":"2000","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/berh.2000.0130_RF78","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/ard.56.8.463","article-title":"Cigarette smoking and rheumatoid arthritis severity","volume":"56","author":"Saag","year":"1997","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1053\/berh.2000.0130_RF79","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/art.1780370408","article-title":"The mortality of rheumatoid arthritis","volume":"37","author":"Wolfe","year":"1994","journal-title":"Arthritis and Rheumatism"},{"key":"10.1053\/berh.2000.0130_RF80","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00124743-199604000-00001","article-title":"Pneumococcal vaccine in rheumatoid arthritis: decreased response while on methotrexate","volume":"2","author":"O'Dell","year":"1996","journal-title":"Journal of Clinical Rheumatology"}],"container-title":["Best Practice &amp; Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169420090130X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169420090130X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T19:06:46Z","timestamp":1733598406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152169420090130X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,3]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,3]]}},"alternative-id":["S152169420090130X"],"URL":"https:\/\/doi.org\/10.1053\/berh.2000.0130","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2001,3]]}}}